Adjuvants for allergy vaccines.

@article{Moingeon2012AdjuvantsFA,
  title={Adjuvants for allergy vaccines.},
  author={Philippe Moingeon},
  journal={Human vaccines & immunotherapeutics},
  year={2012},
  volume={8 10},
  pages={1492-8}
}
Allergen-specific immunotherapy is currently performed via either the subcutaneous or sublingual routes as a treatment for type I (IgE dependent) allergies. Aluminum hydroxide or calcium phosphate are broadly used as adjuvants for subcutaneous allergy vaccines, whereas commercial sublingual vaccines rely upon high doses of aqueous allergen extracts in the absence of any immunopotentiator. Adjuvants to be included in the future in products for allergen specific immunotherapy should ideally… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

The Use of Adjuvants for Enhancing Allergen Immunotherapy Efficacy.

Immunology and allergy clinics of North America • 2016
View 4 Excerpts
Highly Influenced

Mucosal Delivery of Biopharmaceuticals

View 8 Excerpts
Highly Influenced

Aluminium in Allergies and Allergen immunotherapy

The World Allergy Organization journal • 2015
View 3 Excerpts

Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology • 2014
View 2 Excerpts

Similar Papers

Loading similar papers…